QVT Financial, the third largest shareholder of VIVUS, Inc. (NASDAQ:VVUS) (FRA:VIU) plans to vote for the nine-member slate proposed by dissident investor First Manhattan Co.
QVT Financial holds about 8.3 percent stake in the pharmaceutical company.
The investment management firm First Manhattan, earlier received support from proxy advisor Institutional Shareholders Services for three of its nine proposed directors.
The recent support from QVT Financial is a great morale booster for First Manhattan’s efforts to replace VIVUS, Inc. (NASDAQ:VVUS) (FRA:VIU) directors.
First Manhattan’s Views
First Manhattan Co is Vivus’ largest shareholder with...


